FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969171838> ?p ?o ?g. }

• W2969171838 abstract "Men with metastatic castrate-resistant prostate cancer can experience an array of treatment-related side effects. Accumulating evidence suggests exercise may alleviate some of these adversities and assist in disease management. However, empirical evidence in advanced prostate cancer patients remains limited. The purpose of this study is to determine whether men with metastatic prostate cancer, who are ineligible for high-intensity exercise, can partake in a home-based, moderate-intensity exercise program and the impact of doing so on quality of life and physical fitness parameters. Thirty men with adenocarcinoma of the prostate and progressive systemic, metastatic disease will be recruited. Clinicians will screen patients against inclusion criteria to determine eligibility. All men enrolled will be prescribed a tailored, home-based, moderate-intensity exercise intervention consisting of aerobic and strengthening components for 12 weeks. Patients will receive supplementary education materials and weekly behavioural change consultations throughout the intervention. The primary outcome will be the feasibility of delivering such an intervention in men with metastatic disease. Secondary endpoints including skeletal events will be monitored for safety, as will the feasibility of patient-reported outcome measures and the sampling time points, generating data pertaining to completion rates and potential effect in future trials. General physical fitness will be assessed during these visits, using timed sit-to-stand testing and a 6-min walking test. Prior to each visit, objective physical activity levels will be captured for 7 days using an accelerometer, to determine the feasibility of this technology and the quality of data obtained. In parallel with the feasibility aspects of the trial, changes compared to baseline will be reported. Direct regular contact will also serve as a feedback loop, should any issues arise. This study has received ethical approval from the Office for Research Ethics Committees Northern Ireland. This study aims to determine the potential utility of a home-based exercise intervention in managing side effects associated with advanced prostate cancer and its treatment. This feasibility trial will inform the design and implementation of a larger randomised control trial to determine the efficacy of moderate aerobic and strengthening exercise as an adjuvant therapy in men with metastatic prostate cancer. Collecting such evidence provides further support for exercise in this paradigm and potential for its inclusion as a low-toxicity therapy in standard cancer care, in the longer term. ClinicalTrials.gov, NCT03658486 Trial sponsor: Queen’s University Belfast (Reference: B18/15). Contact: Dr. Paula Tighe, Research and Enterprise, Queen’s University Belfast. Telephone: 02890 973,296. Email: p.tighe@qub.ac.uk . The sponsor reviewed the protocol and ethical application prior to submission. Protocol issue: Version 1 (18th May 2018). Authors: MB, MM, SJ and GP." @default.
• W2969171838 created "2019-08-22" @default.
• W2969171838 creator A5028476124 @default.
• W2969171838 creator A5034681607 @default.
• W2969171838 creator A5042029551 @default.
• W2969171838 creator A5048994559 @default.
• W2969171838 creator A5080813119 @default.
• W2969171838 creator A5086399214 @default.
• W2969171838 creator A5087444110 @default.
• W2969171838 date "2019-08-16" @default.
• W2969171838 modified "2023-10-14" @default.
• W2969171838 title "Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT)" @default.
• W2969171838 cites W1575867849 @default.
• W2969171838 cites W1964541767 @default.
• W2969171838 cites W1972215018 @default.
• W2969171838 cites W1973931842 @default.
• W2969171838 cites W1979290264 @default.
• W2969171838 cites W1979447730 @default.
• W2969171838 cites W1981266896 @default.
• W2969171838 cites W2004909463 @default.
• W2969171838 cites W2027748528 @default.
• W2969171838 cites W2031535915 @default.
• W2969171838 cites W2039650731 @default.
• W2969171838 cites W2054952563 @default.
• W2969171838 cites W2060097975 @default.
• W2969171838 cites W2060825434 @default.
• W2969171838 cites W2063931484 @default.
• W2969171838 cites W2074140285 @default.
• W2969171838 cites W2097003384 @default.
• W2969171838 cites W2107946734 @default.
• W2969171838 cites W2112395080 @default.
• W2969171838 cites W2113051457 @default.
• W2969171838 cites W2130607817 @default.
• W2969171838 cites W2136608905 @default.
• W2969171838 cites W2143342727 @default.
• W2969171838 cites W2155827104 @default.
• W2969171838 cites W2157375067 @default.
• W2969171838 cites W2160769891 @default.
• W2969171838 cites W2161431826 @default.
• W2969171838 cites W2162366855 @default.
• W2969171838 cites W2171129594 @default.
• W2969171838 cites W2178014981 @default.
• W2969171838 cites W2224015183 @default.
• W2969171838 cites W2288434672 @default.
• W2969171838 cites W2297046696 @default.
• W2969171838 cites W2320909684 @default.
• W2969171838 cites W2517427649 @default.
• W2969171838 cites W2561066996 @default.
• W2969171838 cites W2588182016 @default.
• W2969171838 cites W2588723417 @default.
• W2969171838 cites W2597360030 @default.
• W2969171838 cites W2621262074 @default.
• W2969171838 cites W2737063847 @default.
• W2969171838 cites W2757235462 @default.
• W2969171838 cites W2766381104 @default.
• W2969171838 cites W2793870468 @default.
• W2969171838 cites W2799646050 @default.
• W2969171838 cites W2802859888 @default.
• W2969171838 cites W2806376672 @default.
• W2969171838 cites W2886471130 @default.
• W2969171838 cites W2894197002 @default.
• W2969171838 cites W2918812541 @default.
• W2969171838 doi "https://doi.org/10.1186/s40814-019-0486-6" @default.
• W2969171838 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6696674" @default.
• W2969171838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31428443" @default.
• W2969171838 hasPublicationYear "2019" @default.
• W2969171838 type Work @default.
• W2969171838 sameAs 2969171838 @default.
• W2969171838 citedByCount "7" @default.
• W2969171838 countsByYear W29691718382020 @default.
• W2969171838 countsByYear W29691718382021 @default.
• W2969171838 countsByYear W29691718382022 @default.
• W2969171838 countsByYear W29691718382023 @default.
• W2969171838 crossrefType "journal-article" @default.
• W2969171838 hasAuthorship W2969171838A5028476124 @default.
• W2969171838 hasAuthorship W2969171838A5034681607 @default.
• W2969171838 hasAuthorship W2969171838A5042029551 @default.
• W2969171838 hasAuthorship W2969171838A5048994559 @default.
• W2969171838 hasAuthorship W2969171838A5080813119 @default.
• W2969171838 hasAuthorship W2969171838A5086399214 @default.
• W2969171838 hasAuthorship W2969171838A5087444110 @default.
• W2969171838 hasBestOaLocation W29691718381 @default.
• W2969171838 hasConcept C103038586 @default.
• W2969171838 hasConcept C121608353 @default.
• W2969171838 hasConcept C126322002 @default.
• W2969171838 hasConcept C143998085 @default.
• W2969171838 hasConcept C159110408 @default.
• W2969171838 hasConcept C1862650 @default.
• W2969171838 hasConcept C2776235491 @default.
• W2969171838 hasConcept C2779134260 @default.
• W2969171838 hasConcept C2779951463 @default.
• W2969171838 hasConcept C2780192828 @default.
• W2969171838 hasConcept C2780665704 @default.
• W2969171838 hasConcept C71924100 @default.
• W2969171838 hasConceptScore W2969171838C103038586 @default.
• W2969171838 hasConceptScore W2969171838C121608353 @default.
• W2969171838 hasConceptScore W2969171838C126322002 @default.
• W2969171838 hasConceptScore W2969171838C143998085 @default.
• W2969171838 hasConceptScore W2969171838C159110408 @default.
• W2969171838 hasConceptScore W2969171838C1862650 @default.

• next